Shyam Srivats
GlaxoSmithKline (United States) · 28 works · 975 citations · h-index 12
Top works
- Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
- Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
- Sigma1 receptors inhibit store-operated Ca2+ entry by attenuating coupling of STIM1 to Orai1
- Therapeutic Potential of Targeting SK1 in Human Cancers
- Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
- Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy
- New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
- Structural Domains Underlying the Activation of Acid-Sensing Ion Channel 2a
- Atomic force microscopy (AFM) imaging suggests that stromal interaction molecule 1 (STIM1) binds to Orai1 with sixfold symmetry
- Naked mole-rat acid-sensing ion channel 3 forms nonfunctional homomers, but functional heteromers
- Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer: AMBER Part 2B
- Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
- An in vivo and in vitro analysis of free radical scavenging potential possessed by Desmodium gangeticum chloroform root extract: interpretation by gsms.
- Activation-induced structural change in the GluN1/GluN3A excitatory glycine receptor
- 596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy
- Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis
- 475 Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade
- Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
- The Sigma1 Receptor Competes with STIM1 to Bind Orai1 to Regulate Store Operated Calcium Entry (SOCE)
- Anti-TIGIT antibody tiragolumab improves PD-L1 blockade via myeloid and Treg cells